The pill, being developed in the Google X lab, contains tiny magnetic particles that travel through the bloodstream looking for malignant cells. Up to 2,000 of the nanoparticles can fit inside one red blood cell and provide physicians with an inside look at their patients.
Google researchers believe the nanoparticles could be coated with antibodies that can bind with proteins or cells linked to a number of illnesses and remain in the blood, continuously reporting new findings, according to the report.
“We want to make it simple and automatic and not invasive,” said Andrew Conrad, head of life sciences at Google X.
More articles on Google:
Google releases Google Fit, challenge to HealthKit
Google symptoms, talk to a doctor
Study: Google Glass improves surgeons’ performance
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
